Occurrence of thymosin β4 in human breast cancer cells and in other cell types of the tumor microenvironment

Human Pathology

Volumn 38, Issue 1, 2007, Pages 114-119

  Larsson, Lars Inge ^a   Holck, Susanne ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Biomarkers; Breast cancer; Endothelial cells; Macrophages; Thymosin

Indexed keywords

THYMOSIN BETA4; THYMOSIN; THYMOSIN BETA(4);

ARTICLE; BREAST CANCER; CANCER CELL; CELL ACTIVITY; CELL HETEROGENEITY; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; MACROPHAGE; MYOFIBROBLAST; PROTEIN EXPRESSION; BREAST TUMOR; CHEMISTRY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; METHODOLOGY; PATHOLOGY; STROMA CELL;

BREAST NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LEUKOCYTES; MACROPHAGES; STROMAL CELLS; THYMOSIN;

EID: 33845315576     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.025     Document Type: Article

References (35)

1. Klein J.J., Goldstein A.L., and White A. Enhancement of in vivo incorporation of labeled precursors into DNA and total protein of mouse lymph nodes after administration of thymic extracts. Proc Natl Acad Sci U S A 53 (1965) 812-817
2. Low T.L., Thurmann G.B., McAdoo M., et al. The chemistry and biology of thymosin. J Biol Chem 254 (1979) 981-986
3. Low T.L., Hu S.K., and Goldstein A.L. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci U S A 78 (1981) 1162-1166
4. Ballweber E., Hannappel E., Huff T., et al. Polymerization of chemically cross-linked actin:thymosin beta(4) complex to filamentous actin: alterations in helical parameters and visualization of thymosin beta(4) binding on F-actin. J Mol Biol 315 (2002) 613-625
5. Sanders M.C., Goldstein A.L., and Wang Y.L. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A 89 (1992) 4678-4682
6. Cha H.J., Jeong M.J., and Kleinman H.K. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95 (2003) 1674-1680
7. Koutrafouri V., Leondiadis L., Avgoustakis K., et al. Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim Biophys Acta 1568 (2001) 60-66
8. Malinda K.M., Sidhu G.S., Mani H., et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 113 (1999) 364-368
9. Philp D., Badamchian M., Scheremeta B., Nguyen M., Goldstein A.L., and Kleinman H.K. Thymosin beta4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen 11 (2003) 19-24
10. Badamchian M., Fagarasan M.O., Danner R.L., Suffredini A.F., Damavandy H., and Goldstein A.L. Thymosin β4 reduces lethality and downmodulates inflammatory mediators in endotoxin induced septic shock. Int Immunopharmacol 3 (2003) 1225-12333
11. Sosne G., Chan C.C., Thai K., et al. Thymosin beta4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res 72 (2001) 605-608
12. Sosne G., Szliter E.A., Barrett R., Kernacki K.A., Kleinman H., and Hazlett L.D. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 74 (2002) 293-299
13. Young J.D., Lawrence A.J., MacLean A.G., et al. Thymosin β4 sulfoxide is an antiinflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 5 (1999) 1424-1427
14. Bock-Marquette I., Saxena A., White M.D., DiMaio J.M., and Srivasta D. Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432 (2004) 466-472
15. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
16. Ji P., Diederichs S., Wang W., et al. MALAT-1, a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22 (2003) 6087-6097
17. Kobayashi T., Okada F., Fujii N., et al. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 160 (2002) 869-882
18. Otto A.M., Müller C.S.G., Huff T., and Hannappel E. Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. J Cancer Res Clin Oncol 128 (2002) 247-256
19. Wang W.S., Chen P.M., Hsiao H.L., Ju S.Y., and Su Y. Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22 (2003) 3297-3306
20. Wang W.S., Chen P.M., Hsiao H.L., Wang H.S., Liang W.Y., and Su Y. Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23 (2004) 6666-6671
21. Yamamoto T., Gotoh M., Kitajima M., and Hirohashi S. Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem Biophys Res Commun 193 (1993) 706-710
22. Dathe V., and Brand-Saberi B. Expression of thymosin beta4 during chick development. Anat Embryol 208 (2004) 27-32
23. Gomez-Marquez J., Franco del Amo F., Carpintero P., and Anadon R. High levels of thymosin beta4 mRNA in differentiating P19 embryonic cells and during development of cardiovascular tissues. Biochim Biophys Acta 1306 (1996) 187-193
24. Goldstein A.L. Thymosin beta4: a new molecular target for antitumor strategies. J Natl Cancer Inst 95 (2003) 1646-1647
25. Olave I.A., Reck-Peterson S.L., and Crabtree G.R. Nuclear actin and actin-related protein in chromatin remodelling. Annu Rev Biochem 71 (2002) 755-781
26. Frohm M., Gunne H., Bergman A.C., et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237 (1996) 86-92
27. Huff T., Müller C.S.G., Otto A.M., Netzker R., and Hannappel E. Beta-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33 (2001) 205-220
28. Larsson L.I. Immunocytochemistry. Theory and practice (1988), CRC Press, Boca Raton (Fla)
29. Elston C.W., and Ellis I.O. Assessment of histological grade. In: Elston C.W., and Ellis I.O. (Eds). Systematic pathology. 3rd ed. vol. 13, The breast (1998), Churchill Livingstone, Edinburgh 365-377
30. Huff T., Rosarius O., Otto A.M., et al. Nuclear localization of the G-actin sequestering peptide thymosin beta4. J Cell Sci 117 (2004) 533-5343
31. Mælan A, Rasmussen TK, Larsson LI, Localization of thymosin- beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility. Histochem Cell Biol (in press)
32. Hall A.K. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 48 (1991) 672-677
33. Chen C., Li M., Yang H., Chai H., Fisher W., and Yao Q. Role of thymosins in cancers and other organ systems. World J Surg 29 (2005) 264-270
34. Wang W.S., Chen P.M., and Su Y. Colorectal carcinoma: from tumorigenesis to treatment. Cell Mol Life Sci 63 (2006) 663-671
35. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70